News
Corvus Pharmaceuticals
CRVS · NASDAQ
$10.23+$0.58 (+6.01%)TodayMarket closed ·
Prev close $9.65
Latest news
- Press releaseGlobe Newswire
Corvus Pharmaceuticals Announces Initiation of Phase 1b Clinical Trial of Soquelitinib for Patients with Hidradenitis Suppurativa
- Press releaseGlobe Newswire
Corvus Pharmaceuticals Announces Publication in Blood of Final Phase 1 Data from the Soquelitinib Phase 1/1b T Cell Lymphoma Trial
- Press releaseGlobe Newswire
Corvus Pharmaceuticals Provides Business Update and Reports Second Quarter 2026 Financial Results
- Press releaseGlobe Newswire
Corvus Pharmaceuticals Announces Additional Investment in Angel Pharmaceuticals to Advance the Development of Soquelitinib in China
- Press releaseGlobe Newswire
Corvus Pharmaceuticals Presents Soquelitinib Phase 1 Atopic Dermatitis Data at the Society for Investigative Dermatology (SID) Annual Meeting
- Press releaseGlobe Newswire
Corvus Pharmaceuticals Provides Business Update and Reports First Quarter 2026 Financial Results
- Press releaseGlobe Newswire
Corvus Pharmaceuticals Appoints Andrew C. Chan, M.D., Ph.D., to Board of Directors
- Press releaseGlobe Newswire
Corvus Pharmaceuticals to Host Investor and Analyst Meeting on May 14, 2026 to Highlight Soquelitinib Data Being Presented at the Society for Investigative Dermatology (SID) Annual Meeting
- NewsAvi Kapoor
Crude Oil Tumbles 12%; State Street Posts Upbeat Earnings
- NewsAvi Kapoor
Autoliv Posts Upbeat Q1 Results, Joins United Airlines, Royal Caribbean Cruises And Other Big Stocks Moving Higher On Friday
- Press releaseGlobe Newswire
Corvus Pharmaceuticals Provides Business Update and Reports Fourth Quarter and Full Year 2025 Financial Results
- News
Earnings Scheduled For March 12, 2026
- News
Smart Money Is Betting Big In CRVS Options
- NewsAvi Kapoor
Netflix, Erasca, Kraft Heinz And Other Big Stocks Moving Lower In Wednesday's Pre-Market Session
- NewsAvi Kapoor
Crude Oil Gains 2%; D.R. Horton Earnings Top Views
- News
Earnings Scheduled For November 4, 2025
- Press releasePRNewswire
The Institute for Follicular Lymphoma Innovation (IFLI) Appoints Innovative Leaders Mehrdad Mobasher, M.D., M.P.H., and Carol O'Hear, M.D., Ph.D., as Executive Partners
- News
Earnings Scheduled For August 7, 2025
- News
12 Health Care Stocks Moving In Friday's Intraday Session
- NewsVandana Singh
Why Is Corvus Pharmaceuticals Stock Soaring On Friday?
- News
12 Health Care Stocks Moving In Friday's Pre-Market Session
- News
12 Health Care Stocks Moving In Thursday's After-Market Session
- News
Earnings Scheduled For May 8, 2025
- NewsAvi Kapoor
Crude Oil Gains Over 1%, General Mills Shares Fall
- NewsAvi Kapoor
Dow Surges 150 Points, US Current Account Deficit Widens In Q3
- News
Market-Moving News for December 18th
- NewsRishabh Mishra
US Stocks To Open Higher As Rate Cut Expectations Surge: All Eyes On Dow Jones To Break Its 9-Day Losing Streak
- News
An Overview of Corvus Pharma's Earnings
- NewsAvi Kapoor
Stellantis, MicroStrategy, Bit Digital And Other Big Stocks Moving Lower In Monday's Pre-Market Session
- News
12 Health Care Stocks Moving In Monday's Pre-Market Session
- NewsAvi Kapoor
Casella Waste Systems, SES AI And Other Big Stocks Moving Lower In Wednesday's Pre-Market Session
- Press releaseBusiness Wire
Kaskela Law LLC Announces Shareholder Investigation of Corvus Pharmaceuticals, Inc. (NASDAQ: CRVS) and Encourages Investors to Contact the Firm
- NewsAvi Kapoor
Why Fortinet Shares Are Trading Higher By Around 17%; Here Are 20 Stocks Moving Premarket
Information on this page is provided for informational purposes only and is not a recommendation to buy, sell or hold any security. Investing involves risk, including possible loss of principal. Market data is delayed at least 15 minutes and is provided without warranty. Analyst ratings, price targets and company data come from third-party sources. Past performance does not guarantee future results.